Detalles de la búsqueda
1.
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.
Eur Radiol
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388716
2.
Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer.
EJNMMI Res
; 13(1): 51, 2023 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37256434
3.
[99mTc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression.
EJNMMI Res
; 13(1): 44, 2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37195370
4.
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study
Cancers (Basel)
; 14(24)2022 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551542
5.
Inter- and intraobserver agreement of the quantitative assessment of [99mTc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer.
EJNMMI Res
; 10(1): 145, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33259032
6.
An evaluation of self-perceived knowledge, attitudes and behaviours of UK oncologists about LGBTQ+ patients with cancer.
ESMO Open
; 5(6): e000906, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33208489
7.
Retraction Note to: Inter- and intraobserver agreement of the quantitative assessment of [99mTc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer.
EJNMMI Res
; 11(1): 102, 2021 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34637006
Resultados
1 -
7
de 7
1
Próxima >
>>